Merck is expanding domestic manufacturing with a $895 million investment in its Kansas factory, one of several major projects ...

U.S. drugmaker Merck said on Tuesday it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

U.S. drug maker Merck is building a $1 billion facility in Wilmington, Delaware, aimed at increasing domestic production of ...

Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic investment as industry-targeted tariffs loom. This 470 ...

Merck is investing $1 billion to build a ... efforts to stimulate economic growth in the U.S., allowing for the domestic production and distribution of medicines and vaccines to patients here ...

Merck announced on Tuesday that it is investing $1 billion in a new Delaware plant to expand domestic production as it ...

The 470,000-square-foot facility will support the launch and commercial production of next-generation biologics and therapies ...

Biopharmaceutical giant Merck (NYSE: MRK) has broken ground on a $1 billion pharmaceutical manufacturing facility in ...

Since the advent of the 2017 Tax Cuts and Jobs Act, Merck has allocated more than $12 billion to enhance its domestic manufacturing and research capabilities, with additional planned investments ...

(Reuters) -Merck Animal Health ... and Gilead have recently announced additional investments to boost domestic production amid U.S. President Donald Trump's tariff policies.

Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic ... and commercial production of next-generation ...